Introduction

The success of Expo Dubai 2020 is not just a celebration of cultural and technological advancements but a profound impact on the global economy. Attracting nearly 200 countries, the event has not only promoted international collaboration but also contributed significantly to Dubai's GDP. According to industry experts, the added revenue from the hotel and leisure industry, as well as retail, is expected to reach AED 89 billion (￡14.4 billion).

The Expo Theme and Sub-themes

The World Exposition is more than just a showcase; it is a solution-finding event focusing on fundamental challenges. Under the theme of “Better Cities, Better Life”, Expo 2020 Dubai addresses key global issues through its three sub-themes: Opportunity, Mobility, and Sustainability. Each sub-theme is represented by its own pavilion, providing an inclusive platform for various nations and organizations to share ideas and innovations.

Al Wasl Plaza: The Main Landmark

Al Wasl Plaza stands as the main landmark of Expo 2020 Dubai, reminiscent of the iconic Eiffel Tower in Paris. This stunning dome-shaped structure represents the architectural excellence and innovative spirit of the Expo. Visitors are treated to a grand experience exploring the various pavilions and exhibitions.

Expo 2020 Dubai: Solutions to Fundamental Challenges

Expo 2020 Dubai is not just about showcasing new ideas but actively contributing to solutions for global challenges. One such example is the Novartis Pharma Corporation, which has used the platform to educate and raise awareness about preventable diseases such as leprosy, malaria, and sickle cell disease. The company, through its Novartis Booth, emphasized the importance of data science, artificial intelligence, and gene therapy in medical advancements.

The Novartis Pharma Corporation at Expo 2020 Dubai

Novartis Pharma Corporation, a leading global pharmaceutical company, participated in the Swiss Pavilion at Expo 2020 Dubai. Speaking from the Opportunity District, Ibrahim Aqel, Head of Novartis Pharma-Patient Access and Public Affairs, highlighted the company's commitment to using technology and innovation to enhance healthcare. Novartis aimed to take visitors on a journey through their four key pillars: Data Science, Artificial Intelligence, Cell and Gene Therapy, and Building Trust with Society and Patient Community.

Interactive Displays and Patient Stories

The Novartis Booth featured interactive touchscreen displays, video rolls, and sensory exhibits. Notable among these were the touchpoints on leprosy, malaria, and sickle cell disease, along with the Malaria Initiative and the Sickle Cell Disease Initiative. A short film by Novartis-affiliated Sandoz showcased the pioneering work of Dr. Mae Dolendo, a pediatric oncologist, in the Southern Philippines Medical Centre in Davao City.

Addressing Rare Diseases: Leprosy and Malaria

In the context of leprosy, the World Health Organization (WHO) reports a rare yet persistent disease, with 202,256 new cases in 161 countries in 2019. The Novartis Foundation, established 40 years ago, has played a crucial role in the establishment of the Global Partnership to Zero Leprosy in 2018. Their efforts focus on early diagnosis and treatment through innovative diagnostic methods and screening initiatives, including contract tracing and preventative treatment programs.

Similarly, malaria remains a significant health concern, with global cases increasing from 228 million in 2018 to 229 million in 2019. While the majority of these cases are in Africa, child mortality due to malaria remains high. Novartis, under its Malaria Initiative, has provided one billion courses of anti-malarial treatment, particularly for children, with no profit.

Challenges and Solutions for Sickle Cell Disease

Sickle Cell Disease (SCD), a genetically-induced life-threatening condition, affects millions of people, especially in Sub-Saharan Africa. According to the WHO, SCD is classified as a public health priority but remains neglected in the global health agenda. The condition causes vascular damage and repeated injury to blood vessels and organs. Novartis, through its Sickle Cell Disease Initiative, has supported healthcare pioneers in providing early diagnosis and treatment to prevent complications, which is crucial given that over 50% of children with SCD in Africa die before their fifth birthday.

Conclusion

Expo Dubai 2020 has demonstrated a significant commitment to innovation, sustainability, and addressing global challenges. The event showcases how collaboration and technological advancements can lead to meaningful solutions for better lives. Novartis and other participants have shown the power of such initiatives in combating preventable diseases and improving healthcare worldwide. As the world continues to face complex challenges, platforms like Expo Dubai 2020 serve as vital forums for collective action and progress.